Literature DB >> 33954935

The role of endocannabinoids in consolidation, retrieval, reconsolidation, and extinction of fear memory.

Ikumi Mizuno1, Shingo Matsuda2,3,4.   

Abstract

Endocannabinoids are involved in various physiological functions, including synaptic plasticity and memory, and some psychiatric disorders, such as posttraumatic stress disorder (PTSD), through the activation of cannabinoid (CB) receptors. Patients with PTSD often show excessive fear memory and impairment of fear extinction (FE). It has been reported that the stability of acquired fear memory is altered through multiple memory stages, such as consolidation and reconsolidation. FE also affects the stability of fear memory. Each stage of fear memory formation and FE are regulated by different molecular mechanisms, including the CB system. However, to the best of our knowledge, no review summarizes the role of the CB system during each stage of fear memory formation and FE. In this review, we summarize the roles of endocannabinoids in fear memory formation and FE. Moreover, based on the summary, we propose a new hypothesis for the role of endocannabinoids in fear regulation, and discuss treatment for PTSD using CB system-related drugs.
© 2021. Maj Institute of Pharmacology Polish Academy of Sciences.

Entities:  

Keywords:  2-AG; AEA; Fear extinction; Fear memory

Mesh:

Substances:

Year:  2021        PMID: 33954935     DOI: 10.1007/s43440-021-00246-y

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  126 in total

1.  Fear extinction in traumatized civilians with posttraumatic stress disorder: relation to symptom severity.

Authors:  Seth D Norrholm; Tanja Jovanovic; Ilana W Olin; Lauren A Sands; India Karapanou; Bekh Bradley; Kerry J Ressler
Journal:  Biol Psychiatry       Date:  2010-10-29       Impact factor: 13.382

2.  Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals.

Authors:  T Ohno-Shosaku; T Maejima; M Kano
Journal:  Neuron       Date:  2001-03       Impact factor: 17.173

3.  Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation.

Authors:  S J Carlisle; F Marciano-Cabral; A Staab; C Ludwick; G A Cabral
Journal:  Int Immunopharmacol       Date:  2002-01       Impact factor: 4.932

4.  N-arachidonoyl-serotonin, a dual FAAH and TRPV1 blocker, inhibits the retrieval of contextual fear memory: Role of the cannabinoid CB1 receptor in the dorsal hippocampus.

Authors:  Pedro H Gobira; Isabel V Lima; Luara A Batista; Antônio C de Oliveira; Leonardo B Resstel; Carsten T Wotjak; Daniele C Aguiar; Fabricio A Moreira
Journal:  J Psychopharmacol       Date:  2017-02-21       Impact factor: 4.153

5.  Anxiety, Stress, and Fear Response in Mice With Reduced Endocannabinoid Levels.

Authors:  Imke Jenniches; Svenja Ternes; Onder Albayram; David M Otte; Karsten Bach; Laura Bindila; Kerstin Michel; Beat Lutz; Andras Bilkei-Gorzo; Andreas Zimmer
Journal:  Biol Psychiatry       Date:  2015-04-14       Impact factor: 13.382

6.  Control of pain initiation by endogenous cannabinoids.

Authors:  A Calignano; G La Rana; A Giuffrida; D Piomelli
Journal:  Nature       Date:  1998-07-16       Impact factor: 49.962

7.  The endogenous cannabinoid system controls extinction of aversive memories.

Authors:  Giovanni Marsicano; Carsten T Wotjak; Shahnaz C Azad; Tiziana Bisogno; Gerhard Rammes; Maria Grazia Cascio; Heike Hermann; Jianrong Tang; Clementine Hofmann; Walter Zieglgänsberger; Vincenzo Di Marzo; Beat Lutz
Journal:  Nature       Date:  2002-08-01       Impact factor: 49.962

8.  Failure to extinguish fear and genetic variability in the human cannabinoid receptor 1.

Authors:  I Heitland; F Klumpers; R S Oosting; D J J Evers; J Leon Kenemans; J M P Baas
Journal:  Transl Psychiatry       Date:  2012-09-25       Impact factor: 6.222

9.  Cutaneous collateral axonal sprouting re-innervates the skin component and restores sensation of denervated Swine osteomyocutaneous alloflaps.

Authors:  Zuhaib Ibrahim; Gigi Ebenezer; Joani M Christensen; Karim A Sarhane; Peter Hauer; Damon S Cooney; Justin M Sacks; Stefan Schneeberger; W P Andrew Lee; Michael Polydefkis; Gerald Brandacher
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

10.  Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study.

Authors:  A Neumeister; M D Normandin; R H Pietrzak; D Piomelli; M Q Zheng; A Gujarro-Anton; M N Potenza; C R Bailey; S F Lin; S Najafzadeh; J Ropchan; S Henry; S Corsi-Travali; R E Carson; Y Huang
Journal:  Mol Psychiatry       Date:  2013-05-14       Impact factor: 15.992

View more
  1 in total

1.  CB2 cannabinoid receptor expression is increased in 129S1/SvImJ mice: behavioral consequences.

Authors:  Marc Ten-Blanco; Inmaculada Pereda-Pérez; Cristina Izquierdo-Luengo; Fernando Berrendero
Journal:  Front Pharmacol       Date:  2022-08-23       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.